诱导多能干细胞瘤变的研究进展
Research Progress in Induced Pluripotent Stem Cell Neoplasia
DOI: 10.12677/ACM.2024.143672, PDF,    科研立项经费支持
作者: 秦 勇：重庆医科大学附属儿童医院放射科，重庆；孙 君*：重庆大学附属中心医院(重庆市急救医疗中心，重庆市第四人民医院)放射科，重庆；谢模芬：重庆市中医院骨科，重庆
关键词: 诱导多能干细胞；生物安全；体内示踪；磁共振成像；Inducing Pluripotent Stem Cells； Biosafety； In Vivo Tracing； Magnetic Resonance Imaging
摘要: 诱导多能干细胞(IPSC)是体细胞重编程后得到的与胚胎干细胞相似的具有自我更新和多向分化潜能的细胞，这一发现成功避开了胚胎干细胞的伦理问题。自IPSC问世，这项技术就迅速应用于疾病建模、药物开发、再生医学和基因调控，尤其是再生医学自体移植研究领域。但是，IPSC移植后瘤变成为IPSC用于再生医学的一大阻碍，因此IPSC的瘤变成为当前IPSC研究的热点问题。本文就IPSC与肿瘤细胞的关系、IPSC移植后成瘤机制、降低IPSC移植后瘤变率以及IPSC移植后体内监测技术等几个方面进行简要综述。
Abstract: IPSC is obtained through somatic cell reprogramming, which has similar self-renewal and mul-ti-directional differentiation potential to embryonic stem cells (ESCs) and avoids the ethical issues of ESCs successfully. Since IPSC was invented, it has been rapidly applied in disease modeling, drug development, regenerative medicine, and gene regulation, especially in the field of regenerative medicine research. However, IPSC post-transplantation tumors have become a major obstacle to the use of IPSC for regenerative medicine, and thus tumors in IPSC have become a hot issue in current IPSC research. This article provides a brief review on the relationship between IPSC and tumor cells, the malignant transformation of IPSC after transplantation and how to reduce it, and in vivo monitoring techniques of IPSC.
文章引用：秦勇, 孙君, 谢模芬. 诱导多能干细胞瘤变的研究进展[J]. 临床医学进展, 2024, 14(3): 105-110. https://doi.org/10.12677/ACM.2024.143672

参考文献

[1] Shi, Y., Desponts, C., Do, J.T., et al. (2008) Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds. Cell Stem Cell, 3, 568-574. [Google Scholar] [CrossRef] [PubMed]
[2] Papapetrou, E.P. (2016) Induced Pluripotent Stem Cells, Past and Future. Science, 353, 991-992. [Google Scholar] [CrossRef] [PubMed]
[3] Yu, J., Vodyanik, M.A., Smuga-Otto, K., et al. (2007) Induced Plu-ripotent Stem Cell Lines Derived from Human Somatic Cells. Science, 318, 1917-1920. [Google Scholar] [CrossRef] [PubMed]
[4] Takahashi, F., Patel, P., Kitsuka, T., et al. (2023) The Exciting Re-alities and Possibilities of IPS-Derived Cardiomyocytes. Bioengineering (Basel), 10, Article No. 237. [Google Scholar] [CrossRef] [PubMed]
[5] Takahashi, J. (2023) Next Steps in Regenerative Medicine. Cell Stem Cell, 30, 509-511. [Google Scholar] [CrossRef] [PubMed]
[6] Okita, K., Ichisaka, T. and Yamanaka, S. (2007) Generation of Germline-Competent Induced Pluripotent Stem Cells. Nature, 448, 313-317. [Google Scholar] [CrossRef] [PubMed]
[7] Semi, K., Matsuda, Y., Ohnishi, K., et al. (2013) Cellular Reprogramming and Cancer Development. International Journal of Cancer, 132, 1240-1248. [Google Scholar] [CrossRef] [PubMed]
[8] Riggs, J.W., Barrilleaux, B.L., Varlakhanova, N., et al. (2013) Induced Pluripotency and Oncogenic Transformation Are Related Processes. Stem Cells and Development, 22, 37-50. [Google Scholar] [CrossRef] [PubMed]
[9] Sarker, D.B., Xue, Y., Mahmud, F., et al. (2024) Interconversion of Cancer Cells and Induced Pluripotent Stem Cells. Cells, 13, Article No. 125. [Google Scholar] [CrossRef] [PubMed]
[10] Ben-Porath, I., Thomson, M.W., Carey, V.J., et al. (2008) An Em-bryonic Stem Cell-Like Gene Expression Signature in Poorly Differentiated Aggressive Human Tumors. Nature Genetics, 40, 499-507. [Google Scholar] [CrossRef] [PubMed]
[11] Orlando, L., Benoit, Y.D., Reid, J.C., et al. (2023) Chemical Genomics Reveals Targetable Programs of Human Cancers Rooted in Pluripotency. Cell Chemical Biology, 30, 780-794. [Google Scholar] [CrossRef] [PubMed]
[12] 蔡菁华. 多能干细胞因子Oct4和Sox2对口腔癌发生发展作用的实验研究[D]: [博士学位论文]. 郑州: 郑州大学, 2016.
[13] Tatavosian, R., Donovan, M.G., Galbraith, M.D., et al. (2023) Cell Differentiation Modifies the P53 Transcriptional Program through a Combination of Gene Silencing and Constitutive Transactivation. Cell Death & Differentiation, 30, 952-965. [Google Scholar] [CrossRef] [PubMed]
[14] 赖永榕. 造血干细胞移植治疗β-地中海贫血的经验[J]. 内科急危重症杂志, 2014, 20(1): 6-8.
[15] 李续娥, 李峰. 地中海贫血骨髓移植中造血干细胞状态及功能的研究[J]. 华南师范大学学报(自然科学版), 2013, 45(1): 10-13.
[16] Isoda, M., Sanosaka, T., Tomooka, R., et al. (2023) Mesenchymal Properties of IPSC-Derived Neural Progenitors That Generate Undesired Grafts after Transplantation. Communications Biology, 6, Article No. 611. [Google Scholar] [CrossRef] [PubMed]
[17] 张曦, 张诚. 造血干细胞移植中的输血相关问题[J]. 中国输血杂志, 2013, 26(3): 103-105.
[18] Yamashita, H. and Hattori, F. (2023) Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells. Journal of Visualized Ex-periments, No. 202. [Google Scholar] [CrossRef] [PubMed]
[19] Amariglio, N., Hirshberg, A., Scheithauer, B.W., et al. (2009) Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient. PLOS Medicine, 6, e1000029. [Google Scholar] [CrossRef] [PubMed]
[20] Kuriyan, A.E., Albini, T.A., Townsend, J.H., et al. (2017) Vi-sion Loss after Intravitreal Injection of Autologous “Stem Cells” for AMD. The New England Journal of Medicine, 376, 1047-1053. [Google Scholar] [CrossRef] 
[21] Berkowitz, A.L., Miller, M.B., Mir, S.A., et al. (2016) Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism”. The New England Journal of Medicine, 375, 196-198. [Google Scholar] [CrossRef] 
[22] Zhu, S., Li, W., Zhou, H., et al. (2010) Reprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds. Cell Stem Cell, 7, 651-655. [Google Scholar] [CrossRef] [PubMed]
[23] 龙媛, 张立红, 谢欣. 改变细胞命运的重编程[J]. 生命科学, 2015, 27(3): 327-335.
[24] 刘治威, 马可为, 云志中, 等. 小分子化合物诱导体细胞重编程为多能干细胞的研究进展[J]. 世界最新医学信息文摘, 2017, 17(8): 47-48.
[25] Zhang, P.W., Haidet-Phillips, A.M., Pham, J.T., et al. (2016) Generation of GFAP::GFP Astrocyte Reporter Lines from Human Adult Fibroblast-Derived IPS Cells Using Zinc-Finger Nuclease Technology. Glia, 64, 63-75. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, Y., Zheng, Y., Li, S., et al. (2017) Human Neural Progenitors Derived from Integration-Free IPSCs for SCI Therapy. Stem Cell Research, 19, 55-64. [Google Scholar] [CrossRef] [PubMed]
[27] Ha, J.L., Kaser, E., Guan, T., et al. (2024) Up and Away with Cer-vical Cancer: IL-29 Is a Promising Cytokine for Immunotherapy of Cervical Cancer Due to Its Powerful Upregulation of P18, P27, and TRAILR1. Medical Oncology, 41, Article No. 65. [Google Scholar] [CrossRef] [PubMed]
[28] Contreras-Jurado, C., Montero-Pedrazuela, A., Perez, R.F., et al. (2023) The Thyroid Hormone Enhances Mouse Embryonic Fibroblasts Reprogramming to Pluripotent Stem Cells: Role of the Nuclear Receptor Corepressor 1. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1235614. [Google Scholar] [CrossRef] [PubMed]
[29] Nguyen, V.P., Fan, W., Zhu, T., et al. (2021) Long-Term, Noninvasive in Vivo Tracking of Progenitor Cells Using Multimodality Photoacoustic, Optical Coherence Tomography, and Fluorescence Imaging. ACS Nano, 15, 13289-13306. [Google Scholar] [CrossRef] [PubMed]
[30] Yang, J., Yan, M., Wang, Z., et al. (2023) Optical and MRI Mul-timodal Tracing of Stem Cells in Vivo. Molecular Imaging, 2023, Article ID: 4223485. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, G., Lin, S., Huang, D., et al. (2018) Revealing the Fate of Transplanted Stem Cells in Vivo with a Novel Optical Imaging Strategy. Small, 14, Article ID: 1702679. [Google Scholar] [CrossRef] [PubMed]
[32] Kraunsoe, S., Azami, T., Pei, Y., et al. (2023) Requirement for STAT3 and Its Target, TFCP2L1, in Self-Renewal of Naive Pluripotent Stem Cells in Vivo and in Vitro. Biology Open, 12, bio059650. [Google Scholar] [CrossRef] [PubMed]
[33] 黄思渝, 成昱, 秦瑶. 纳米示踪剂在移植干细胞活体示踪中的研究进展[J]. 同济大学学报(医学版), 2021, 42(2): 158-166.
[34] Li, K., Chan, C.T., Nejadnik, H., et al. (2018) Ferumoxytol-Based Dual-Modality Imaging Probe for Detection of Stem Cell Transplant Rejection. Nanotheranostics, 2, 306-319. [Google Scholar] [CrossRef] [PubMed]
[35] Riegler, J., Ebert, A., Qin, X., et al. (2016) Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas. Stem Cell Reports, 6, 176-187. [Google Scholar] [CrossRef] [PubMed]
[36] Namestnikova, D.D., Gubskiy, I.L., Revkova, V.A., et al. (2021) Intra-Arterial Stem Cell Transplantation in Experimental Stroke in Rats: Real-Time MR Visualization of Transplanted Cells Starting with Their First Pass through the Brain with Regard to the Therapeutic Action. Frontiers in Neuroscience, 15, Article ID: 641970. [Google Scholar] [CrossRef] [PubMed]
[37] Cherkashova, E.A., Namestnikova, D.D., Gubskiy, I.L., et al. (2023) Dynamic MRI of the Mesenchymal Stem Cells Distribution during Intravenous Transplantation in a Rat Model of Ischemic Stroke. Life (Basel), 13, Article No. 288. [Google Scholar] [CrossRef] [PubMed]

为你推荐